YOUR FULL GUIDE TO COMPOUNDED SEMAGLUTIDE
Compounded Semaglutide Weight Management Injections *
LaserAway now offers Compounded Semaglutide Injections for weight loss.
WHAT IS COMPOUNDED SEMAGLUTIDE?
Compounded Semaglutide is a prescription-only medication. It works by mimicking the GLP-1 hormone to regulate insulin release, slow stomach emptying, and reduce appetite.
*Prescription products require a consultation with a medical professional. Compounded drugs are not approved or evaluated for safety or efficacy by the FDA.
What To Expect
Our in-clinic medical team will evaluate your prescription eligibility based on an exam and information you provide during your initial consultation. They will work closely with you to discuss your options and tailor a program that is right for you.
Compounded Semaglutide is administered through a simple weekly subcutaneous injection. Injections are administered in-clinic by trained professionals.
Our medical team will meet with you weekly to evaluate your progress and recommend any program changes.
Results may vary based on each person’s personal medical situation as well as diet, exercise, and other factors. However, studies have found that Compounded Semaglutide has been very effective in helping individuals achieve substantial weight loss versus a placebo, when accompanied by a reduction in calories and increased exercise. (Source 1 | Source 2) Compounded Semaglutide has been widely researched for the purpose of treating obesity and has been approved for weight loss and weight management by the FDA.
Top Benefits
• Safe, sustainable weight loss
• Administered in-clinic by licensed medical professionals
• Dosage personalized and monitored to ensure best results
• Convenient, easy, and hassle-free appointments
• Effectively targets GLP-1 receptors to reduce appetite & more
*Results and patient experience may vary
How It Works
GLP-1 weight loss medications work by mimicking a natural hormone in the body that helps regulate appetite and blood sugar levels.
The active ingredients in these medications have been shown to slow down digestion, reduce hunger, and increase feelings of fullness, making it easier to consume fewer calories and support sustainable weight loss. They’re best used alongside a healthy diet and exercise plan for optimal results.
WHAT ARE THE SIDE EFFECTS OF COMPOUNDED SEMAGLUTIDE?
Like other GLP-1 medications, Compounded Semaglutide comes with the risk of potential side effects.
POTENTIAL SIDE EFFECTS & RISKS:
While weight management peptide injections are generally considered safe, the following side effects and risks have been associated with this medication:
COMMON SIDE EFFECTS:
• Nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia (indigestion), dizziness, eructation, abdominal distention, belching, hypoglycemia (low blood sugar), flatulence, gastroenteritis, hair loss, heartburn, and gastroesophageal reflux disease (GERD).
• Injection Site Reactions: Itching, burning, or skin thickening at the injection site (welting).
• Hypoglycemia: Particularly if combined with other medications that lower blood sugar, such as insulin or sulfonylureas (e.g., glyburide, glipizide, glimepiride, tolbutamide).
LESS COMMON BUT SERIOUS SIDE EFFECTS:
• Pancreatitis: Rare but may present with severe abdominal pain; seek medical attention immediately.
• Gallbladder Disease: Increased risk of gallstones.
• Kidney Issues: Possible risk of acute kidney injury, particularly if experiencing nausea or dehydration.
• Vision Changes: In individuals with type 2 diabetes.
• Serious Allergic Reactions: Rash, itching/swelling (especially of the face, tongue, or throat), severe dizziness, difficulty breathing, or other signs of a severe reaction.
• Increase in heart rate (heart racing that lasts for several minutes), depression, or thoughts of suicide.
• Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
• Suicidal Behavior and Ideation: You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
• Thyroid C-Cell Tumors: In mice and rats, semaglutide caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether semaglutide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza and Saxenda) after the drug was put on the market. Semaglutide should not be used if you have a family history of MTC or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider right away if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Important Safety Information
Certain medical conditions may increase the risk of side effects or make the Compounded Semaglutide unsuitable.
• Personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2). This medication may increase the risk of thyroid tumors based on animal studies, though human effects are unknown.
• Problems with your pancreas, including a history of pancreatitis.
• Kidney problems or impairment.
• Severe stomach issues, such as gastroparesis or other digestive disorders.
• A history of diabetic retinopathy.
• Current pregnancy, plans to become pregnant, or if breastfeeding.
• Type 1 diabetes or type 2 diabetes and are taking insulin or other hypoglycemic medications without consulting an endocrinologist, as this combination may increase hypoglycemia risk.
• Gallbladder issues
• Ileus
• Diabetic retinopathy
• History of eating disorders.
• Depression, suicidal thoughts or behavior, or a history of a suicide attempt.
• Known drug allergies, as this product may contain inactive ingredients that could cause allergic reactions.
DRUG INTERACTIONS:
The following drug interactions may occur or have harmful impacts with Compounded Semaglutide:
• Anti-Diabetic Agents: Taking insulin and sulfonylureas, may increase hypoglycemia risk when combined with weight management peptide injections.
• GLP-1 Agonists: Similar medications, including Ozempic, Zepbound, Monjourno, Wegovy, Adiyxin, Byetta, Bydureon, Rybelsus, Trulicity, Victoza, and others, should not be taken concurrently with weight management peptide injections.
Weight management peptide injections may also reduce the effectiveness of oral contraceptives. It is advised to use a non-oral contraceptive or barrier method for four (4) weeks after starting the Treatment and after each dose increase until reaching a maintenance dose.